Sri Adhikari Brothers Television Network Ltd. (SABTNL) Charts New Technology-Led Future with Strategic Transformation and 50 MW AI & Green Data Centre Proposal
Sri Adhikari Brothers Television Network Ltd. (SABTNL) (BSE 530943) (NSE: SABTNL) (ISIN:…
Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
HKUST Receives Government’s Approval to Establish a New Medical School
Dedicated to Nurturing a New Generation of DoctorsSupporting Hong Kong Become a…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…
Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease
In Canada, lecanemab is indicated for the treatment of adult patients with…
Cipla Health welcomes FSSAI’s new labelling rules for ‘ORS’, reinforces Prolyte ORS as the #AsliORS
MUMBAI, India, Oct. 24, 2025 /PRNewswire/ -- ProlyteORS, the flagship brand of…
izmo Ltd. Receives Prestigious DSIR Recognition for In-House R&D Unit
BANGALORE, India, Oct. 16, 2025 /PRNewswire/ -- izmo Ltd., has been formally…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Following the Appointment of Dr. Doug Buerger as COO, Jiuzi Holdings, Inc.’s Board Endorses Crypto Asset Investment Policy Allowing Up to $1 Billion Deployment
HANGZHOU, China, Sept. 24, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN;…
NEXEN TIRE Secures SBTi Approval for Greenhouse Gas Reduction Targets
Committed to reducing direct and indirect greenhouse gas emissions through systematic and…
